GranuLab is a medical device manufacturer of synthetic bone grafts. GranuLab has been known as one of the world’s key manufacturing companies for the Hydroxyapatite market and has also been Halal certified by JAKIM (Department of Islamic Development Malaysia).

Granulab is 70% owned by Reneuco – a Public Listed Company, while the balance of 30% is owned by SIRIM – a corporate organization wholly owned by the Malaysian government under the Ministry of Finance Incorporated. Granulab manufacturing facility is certified with ISO 13485:2016 by BSI, Netherland. The facility is well equipped and capable of producing multiple types, forms, shapes, and sizes of synthetic bone grafts to cater to the needs of clients hospitals, and patients.


Granulab is committed to producing and delivering high-quality products, consistently meeting :

  • Consumer requirements
  • Ethical standards and
  • Legal and regulatory requirements

Granulab is committed to maintaining and improving the effectiveness of its quality management system in compliance with ISO 13485:2016, BSI Netherlands, and European Regulation.

Granulab takes product performance and effectiveness as well as patient safety to be the highest priority. We are committed to applying continuous improvement and risk management in accordance with industrial standards.

Granulab appreciates the importance of a competent workforce in materializing quality processes and products. Staff growth and development are instrumental in overall organizational performance.


Our products are being trusted and acknowledged by: